CH25H and myeloid neoplasm: We further confirmed that normal CD34-positive cells present hypomethylated status of the promoter region of CH25H. Therefore, we propose a hypothesis that CH25H is one of the candidate genes whose methylation status is related to myeloid neoplasms and one of the target genes of DNMT inhibitors.